Sequence-Based Protein–Protein Interaction Prediction and Its Applications in Drug Discovery
Cells · 2025
DOI: 10.3390/cells14181449 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von François Charih und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems and Computer Engineering, Carleton University, Ottawa, ON K1S 5B6, Canada. Hauptthemen laut MEDLINE: Drug Discovery, Protein Interaction Mapping, Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Council of Canada, National Science and Engineering Research Council (NSERC) Canada Discovery, François Charih’s early doctoral studies.
Abstract (Originalsprache)
Aberrant protein–protein interactions (PPIs) underpin a plethora of human diseases, and disruption of these harmful interactions constitute a compelling treatment avenue. Advances in computational approaches to PPI prediction have closely followed progress in deep learning and natural language processing. In this review, we outline the state-of-the-art methods for sequence-based PPI prediction and explore their impact on target identification and drug discovery. We begin with an overview of commonly used training data sources and techniques used to curate these data to enhance the quality of the training set. Subsequently, we survey various PPI predictor types, including traditional similarity-based approaches, and deep learning-based approaches with a particular emphasis on transformer architecture. Finally, we provide examples of PPI prediction in system-level proteomics analyses, target identification, and designs of therapeutic peptides and antibodies. This review sheds light on sequence-based PPI prediction, a broadly applicable alternative to structure-based methods, from a unique perspective that emphasizes their roles in the drug discovery process and rigorous model assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems and Computer Engineering, Carleton University, Ottawa, ON K1S 5B6, Canada.
- Institute of Biochemistry, Department of Biology, Carleton University, Ottawa, ON K1S 5B6, Canada.
- NuvoBio Corporation, Ottawa, ON K1M 2J2, Canada.
ORCID-Profile: François Charih, James R Green
Förderung
- Natural Sciences and Engineering Council of Canada
- National Science and Engineering Research Council (NSERC) Canada Discovery
- François Charih’s early doctoral studies
Zitieren
APA
Charih, F., Green, J. R., & Biggar, K. K. (2025). Sequence-Based Protein–Protein Interaction Prediction and Its Applications in Drug Discovery. Cells. https://doi.org/10.3390/cells14181449
Vancouver
Charih F, Green JR, Biggar KK. Sequence-Based Protein–Protein Interaction Prediction and Its Applications in Drug Discovery. Cells. 2025. doi:10.3390/cells14181449
BibTeX
@article{Charih2025,
author = {Charih, François and Green, James R and Biggar, Kyle K},
title = {Sequence-Based Protein–Protein Interaction Prediction and Its Applications in Drug Discovery},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14181449}
}
EUVIMED